Interaction of JAK with steroid receptor function

References

• Leonard WJ, O’Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol 1998; 16:293 - 322; http://dx.doi.org/10.1146/annurev.immunol.16.1.293; PMID: 9597132
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Saharinen P, Pesu M, Holt VE 3rd, Silvennoinen O, O’Shea JJ. The Janus kinases (Jaks). Genome Biol 2004; 5:253; http://dx.doi.org/10.1186/gb-2004-5-12-253; PMID: 15575979
   PubMed Web of Science ®Google Scholar
• Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene 2000; 19:5662 - 79; http://dx.doi.org/10.1038/sj.onc.1203925; PMID: 11114747
   PubMed Web of Science ®Google Scholar
• Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004; 117:1281 - 3; http://dx.doi.org/10.1242/jcs.00963; PMID: 15020666
   PubMed Web of Science ®Google Scholar
• Boudny V, Kovarik J. JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription. Neoplasma 2002; 49:349 - 55; PMID: 12584581
   PubMed Web of Science ®Google Scholar
• Verma A, Kambhampati S, Parmar S, Platanias LC. Jak family of kinases in cancer. Cancer Metastasis Rev 2003; 22:423 - 34; http://dx.doi.org/10.1023/A:1023805715476; PMID: 12884916
   PubMed Web of Science ®Google Scholar
• Wagner KU, Rui H. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mammary Gland Biol Neoplasia 2008; 13:93 - 103; http://dx.doi.org/10.1007/s10911-008-9062-z; PMID: 18228120
   PubMed Web of Science ®Google Scholar
• LaFave LM, Levine RL. JAK2 the future: therapeutic strategies for JAK-dependent malignancies. Trends Pharmacol Sci 2012; 33:574 - 82; http://dx.doi.org/10.1016/j.tips.2012.08.005; PMID: 22995223
   PubMed Web of Science ®Google Scholar
• Stein BL, Crispino JD, Moliterno AR. Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasms. Curr Opin Oncol 2011; 23:609 - 16; PMID: 21993415
   PubMed Web of Science ®Google Scholar
• Menet CJ, Rompaey LV, Geney R. Advances in the discovery of selective JAK inhibitors. Prog Med Chem 2013; 52:153 - 223; PMID: 23384668
   PubMedGoogle Scholar
• Wang L, Zhang X, Farrar WL, Yang X. Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. Cell Mol Immunol 2004; 1:416 - 24; PMID: 16293210
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835 - 9; http://dx.doi.org/10.1016/0092-8674(95)90199-X; PMID: 8521507
   PubMed Web of Science ®Google Scholar
• Zhang Z, Burch PE, Cooney AJ, Lanz RB, Pereira FA, Wu J, et al. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Res 2004; 14:580 - 90; http://dx.doi.org/10.1101/gr.2160004; PMID: 15059999
   PubMed Web of Science ®Google Scholar
• Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009; 150:2537 - 42; http://dx.doi.org/10.1210/en.2009-0070; PMID: 19372199
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999; 97:161 - 3; http://dx.doi.org/10.1016/S0092-8674(00)80726-6; PMID: 10219237
   PubMed Web of Science ®Google Scholar
• Novac N, Heinzel T. Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 2004; 3:335 - 46; http://dx.doi.org/10.2174/1568010042634541; PMID: 15584884
   PubMedGoogle Scholar
• Levin ER. Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 2011; 25:377 - 84; http://dx.doi.org/10.1210/me.2010-0284; PMID: 20861220
   PubMed Web of Science ®Google Scholar
• McKenna NJ, O’Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002; 108:465 - 74; http://dx.doi.org/10.1016/S0092-8674(02)00641-4; PMID: 11909518
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83:841 - 50; http://dx.doi.org/10.1016/0092-8674(95)90200-7; PMID: 8521508
   PubMed Web of Science ®Google Scholar
• Kininis M, Kraus WL. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal 2008; 6:e005; PMID: 18301785
   PubMedGoogle Scholar
• Geserick C, Meyer HA, Haendler B. The role of DNA response elements as allosteric modulators of steroid receptor function. Mol Cell Endocrinol 2005; 236:1 - 7; http://dx.doi.org/10.1016/j.mce.2005.03.007; PMID: 15876478
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204:105 - 14; http://dx.doi.org/10.1677/JOE-09-0242; PMID: 19767412
   PubMed Web of Science ®Google Scholar
• Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 1896; 2:104 - 7; http://dx.doi.org/10.1016/S0140-6736(01)72307-0
   Google Scholar
• Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004; 51:55 - 67; http://dx.doi.org/10.1016/j.critrevonc.2004.02.001; PMID: 15207254
   PubMed Web of Science ®Google Scholar
• Weigel NL, Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl) 1998; 76:469 - 79; http://dx.doi.org/10.1007/s001090050241; PMID: 9660165
   PubMed Web of Science ®Google Scholar
• Coleman KM, Smith CL. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci 2001; 6:D1379 - 91; http://dx.doi.org/10.2741/Coleman; PMID: 11578956
   PubMed Web of Science ®Google Scholar
• Weigel NL, Moore NL. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 2007; 21:2311 - 9; http://dx.doi.org/10.1210/me.2007-0101; PMID: 17536004
   PubMed Web of Science ®Google Scholar
• Song RX, Chen Y, Zhang Z, Bao Y, Yue W, Wang JP, et al. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells. J Steroid Biochem Mol Biol 2010; 118:219 - 30; http://dx.doi.org/10.1016/j.jsbmb.2009.09.018; PMID: 19815064
   PubMed Web of Science ®Google Scholar
• Gupta N, Grebhardt S, Mayer D. Janus kinase 2--a novel negative regulator of estrogen receptor α function. Cell Signal 2012; 24:151 - 61; http://dx.doi.org/10.1016/j.cellsig.2011.08.016; PMID: 21907792
   PubMed Web of Science ®Google Scholar
• de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010; 70:9175 - 84; http://dx.doi.org/10.1158/0008-5472.CAN-10-1318; PMID: 20978187
   PubMed Web of Science ®Google Scholar
• Yeh YT, Ou-Yang F, Chen IF, Yang SF, Su JH, Hou MF, et al. Altered p-JAK1 expression is associated with estrogen receptor status in breast infiltrating ductal carcinoma. Oncol Rep 2007; 17:35 - 9; PMID: 17143475
   PubMed Web of Science ®Google Scholar
• Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207:12 - 22; http://dx.doi.org/10.1002/jcp.20472; PMID: 16110483
   PubMed Web of Science ®Google Scholar
• Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N. Leptin signaling in breast cancer: an overview. J Cell Biochem 2008; 105:956 - 64; http://dx.doi.org/10.1002/jcb.21911; PMID: 18821585
   PubMed Web of Science ®Google Scholar
• Andò S, Catalano S. The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol 2012; 8:263 - 75; http://dx.doi.org/10.1038/nrendo.2011.184; PMID: 22083089
   PubMed Web of Science ®Google Scholar
• Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 1987; 8:115 - 31; http://dx.doi.org/10.1210/edrv-8-2-115; PMID: 3301316
   PubMed Web of Science ®Google Scholar
• Goffin V, Kelly PA. The prolactin/growth hormone receptor family: structure/function relationships. J Mammary Gland Biol Neoplasia 1997; 2:7 - 17; http://dx.doi.org/10.1023/A:1026313211704; PMID: 10887515
   PubMed Web of Science ®Google Scholar
• Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS2. Proc Natl Acad Sci U S A 2003; 100:1016 - 21; http://dx.doi.org/10.1073/pnas.0337600100; PMID: 12552091
   PubMed Web of Science ®Google Scholar
• Leung KC, Brce J, Doyle N, Lee HJ, Leong GM, Sjögren K, et al. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases. Endocrinology 2007; 148:2417 - 23; http://dx.doi.org/10.1210/en.2006-1305; PMID: 17272397
   PubMed Web of Science ®Google Scholar
• Bachelot A, Binart N. Reproductive role of prolactin. Reproduction 2007; 133:361 - 9; http://dx.doi.org/10.1530/REP-06-0299; PMID: 17307904
   PubMed Web of Science ®Google Scholar
• Frasor J, Gibori G. Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 2003; 14:118 - 23; http://dx.doi.org/10.1016/S1043-2760(03)00030-4; PMID: 12670737
   PubMed Web of Science ®Google Scholar
• Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 2001; 15:1941 - 52; http://dx.doi.org/10.1210/me.15.11.1941; PMID: 11682625
   PubMed Web of Science ®Google Scholar
• Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 1995; 270:16449 - 57; http://dx.doi.org/10.1074/jbc.270.27.16449; PMID: 7608217
   PubMed Web of Science ®Google Scholar
• Lange CA. Integration of progesterone receptor action with rapid signaling events in breast cancer models. J Steroid Biochem Mol Biol 2008; 108:203 - 12; http://dx.doi.org/10.1016/j.jsbmb.2007.09.019; PMID: 17964138
   PubMed Web of Science ®Google Scholar
• Lange CA, Richer JK, Horwitz KB. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 1999; 13:829 - 36; http://dx.doi.org/10.1210/me.13.6.829; PMID: 10379882
   PubMed Web of Science ®Google Scholar
• Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, et al. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 2005; 25:4826 - 40; http://dx.doi.org/10.1128/MCB.25.12.4826-4840.2005; PMID: 15923602
   PubMed Web of Science ®Google Scholar
• Sagare-Patil V, Modi D. Progesterone activates Janus Kinase 1/2 and activators of transcription 1 (JAK1-2/STAT1) pathway in human spermatozoa. Andrologia 2013; 45:178 - 86; http://dx.doi.org/10.1111/j.1439-0272.2012.01332.x; PMID: 22748021
   PubMed Web of Science ®Google Scholar
• Laflamme J, Akoum A, Leclerc P. Induction of human sperm capacitation and protein tyrosine phosphorylation by endometrial cells and interleukin-6. Mol Hum Reprod 2005; 11:141 - 50; http://dx.doi.org/10.1093/molehr/gah142; PMID: 15665187
   PubMed Web of Science ®Google Scholar
• Lachance C, Leclerc P. Mediators of the Jak/STAT signaling pathway in human spermatozoa. Biol Reprod 2011; 85:1222 - 31; http://dx.doi.org/10.1095/biolreprod.111.092379; PMID: 21880948
   PubMed Web of Science ®Google Scholar
• Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002; 20:3001 - 15; http://dx.doi.org/10.1200/JCO.2002.10.018; PMID: 12089231
   PubMed Web of Science ®Google Scholar
• Ueda T, Bruchovsky N, Sadar MD. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 2002; 277:7076 - 85; http://dx.doi.org/10.1074/jbc.M108255200; PMID: 11751884
   PubMed Web of Science ®Google Scholar
• Kanda T, Steele R, Ray R, Ray RB. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol 2008; 82:11066 - 72; http://dx.doi.org/10.1128/JVI.01300-08; PMID: 18768969
   PubMed Web of Science ®Google Scholar
• Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray RB, Chang C, et al. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer 2010; 1:859 - 67; http://dx.doi.org/10.1177/1947601910383417; PMID: 21779469
   PubMedGoogle Scholar
• Martinez HD, Hsiao JJ, Jasavala RJ, Hinkson IV, Eng JK, Wright ME. Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells. Genes Cancer 2011; 2:956 - 78; http://dx.doi.org/10.1177/1947601912436422; PMID: 22701762
   PubMedGoogle Scholar
• Lefrancois-Martinez AM, Blondet-Trichard A, Binart N, Val P, Chambon C, Sahut-Barnola I, et al. Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor. J Biol Chem 2011; 286:32976 - 85; http://dx.doi.org/10.1074/jbc.M111.218016; PMID: 21808064
   PubMed Web of Science ®Google Scholar
• Johnston CI. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens Suppl 1992; 10:S13 - 26; PMID: 1337911
   PubMedGoogle Scholar
• Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am J Physiol 1998; 275:C1216 - 23; PMID: 9814969
   PubMedGoogle Scholar
• Li J, Feltzer RE, Dawson KL, Hudson EA, Clark BJ. Janus kinase 2 and calcium are required for angiotensin II-dependent activation of steroidogenic acute regulatory protein transcription in H295R human adrenocortical cells. J Biol Chem 2003; 278:52355 - 62; http://dx.doi.org/10.1074/jbc.M305232200; PMID: 14565954
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, Tateno T, et al. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 2005; 146:3900 - 6; http://dx.doi.org/10.1210/en.2004-1674; PMID: 15932931
   PubMed Web of Science ®Google Scholar
• Saha S, Bornstein SR, Graessler J, Kopprasch S. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways. Cell Tissue Res 2012; 348:71 - 80; http://dx.doi.org/10.1007/s00441-012-1346-3; PMID: 22331364
   PubMed Web of Science ®Google Scholar
• Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol 1996; 60:563 - 72; PMID: 8929546
   PubMed Web of Science ®Google Scholar
• Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc 2004; 1:239 - 46; http://dx.doi.org/10.1513/pats.200402-005MS; PMID: 16113441
   PubMedGoogle Scholar
• Bianchi M, Meng C, Ivashkiv LB. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc Natl Acad Sci U S A 2000; 97:9573 - 8; http://dx.doi.org/10.1073/pnas.160099797; PMID: 10920190
   PubMed Web of Science ®Google Scholar
• Haffner MC, Jurgeit A, Berlato C, Geley S, Parajuli N, Yoshimura A, et al. Interaction and functional interference of glucocorticoid receptor and SOCS1. J Biol Chem 2008; 283:22089 - 96; http://dx.doi.org/10.1074/jbc.M801041200; PMID: 18524780
   PubMed Web of Science ®Google Scholar
• Greenstein S, Ghias K, Krett NL, Rosen ST. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 2002; 8:1681 - 94; PMID: 12060604
   PubMed Web of Science ®Google Scholar
• Almawi WY, Melemedjian OK. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 2002; 71:9 - 15; PMID: 11781376
   PubMed Web of Science ®Google Scholar
• Krasil’nikov M, Shatskaya V. Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones. J Steroid Biochem Mol Biol 2002; 82:369 - 76; http://dx.doi.org/10.1016/S0960-0760(02)00223-6; PMID: 12589944
   PubMed Web of Science ®Google Scholar
• Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101:545 - 59; http://dx.doi.org/10.1161/CIRCRESAHA.107.156596; PMID: 17872473
   PubMed Web of Science ®Google Scholar
• Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997; 46:717 - 9; http://dx.doi.org/10.2337/diabetes.46.4.717; PMID: 9075817
   PubMed Web of Science ®Google Scholar
• Ishida-Takahashi R, Uotani S, Abe T, Degawa-Yamauchi M, Fukushima T, Fujita N, et al. Rapid inhibition of leptin signaling by glucocorticoids in vitro and in vivo. J Biol Chem 2004; 279:19658 - 64; http://dx.doi.org/10.1074/jbc.M310864200; PMID: 14993217
   PubMed Web of Science ®Google Scholar
• Douer D, Ramezani L, Parker J, Levine AM. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells. Leukemia 2000; 14:874 - 81; http://dx.doi.org/10.1038/sj.leu.2401772; PMID: 10803520
   PubMed Web of Science ®Google Scholar
• Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D, Hoang T. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. Blood 1998; 92:607 - 15; PMID: 9657762
   PubMed Web of Science ®Google Scholar
• Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002; 16:1896 - 905; http://dx.doi.org/10.1038/sj.leu.2402718; PMID: 12357341
   PubMed Web of Science ®Google Scholar
• Si J, Collins SJ. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood 2002; 100:4401 - 9; http://dx.doi.org/10.1182/blood-2001-12-0374; PMID: 12393611
   PubMed Web of Science ®Google Scholar
• Herrera F, Chen Q, Schubert D. Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression. J Biol Chem 2010; 285:38915 - 22; http://dx.doi.org/10.1074/jbc.M110.170274; PMID: 20876578
   PubMed Web of Science ®Google Scholar
• Murray M, Butler AM, Fiala-Beer E, Su GM. Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver. FEBS Lett 2005; 579:3669 - 73; http://dx.doi.org/10.1016/j.febslet.2005.05.052; PMID: 15963505
   PubMed Web of Science ®Google Scholar
• Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008; 29:388 - 96; http://dx.doi.org/10.1016/j.mam.2008.07.003; PMID: 18755215
   PubMed Web of Science ®Google Scholar
• Kovalenko PL, Zhang Z, Cui M, Clinton SK, Fleet JC. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1. BMC Genomics 2010; 11:26; http://dx.doi.org/10.1186/1471-2164-11-26; PMID: 20070897
   PubMed Web of Science ®Google Scholar
• Muthian G, Raikwar HP, Rajasingh J, Bright JJ. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83:1299 - 309; http://dx.doi.org/10.1002/jnr.20826; PMID: 16547967
   PubMed Web of Science ®Google Scholar
• Morales O, Faulds MH, Lindgren UJ, Haldosén LA. 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. J Biol Chem 2002; 277:34879 - 84; http://dx.doi.org/10.1074/jbc.M204819200; PMID: 12107179
   PubMed Web of Science ®Google Scholar
• Wahli W, Braissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more... Chem Biol 1995; 2:261 - 6; http://dx.doi.org/10.1016/1074-5521(95)90045-4; PMID: 9383428
   PubMed Web of Science ®Google Scholar
• Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 2006; 45:120 - 59; http://dx.doi.org/10.1016/j.plipres.2005.12.002; PMID: 16476485
   PubMed Web of Science ®Google Scholar
• Peters JM, Cattley RC, Gonzalez FJ. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 1997; 18:2029 - 33; http://dx.doi.org/10.1093/carcin/18.11.2029; PMID: 9395198
   PubMed Web of Science ®Google Scholar
• Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15:3012 - 22; PMID: 7539101
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Yamada J, Suga T. Effects of testosterone, hypophysectomy and growth hormone treatment on clofibrate induction of peroxisomal beta-oxidation in female rat liver. Biochem Pharmacol 1994; 47:918 - 21; http://dx.doi.org/10.1016/0006-2952(94)90494-4; PMID: 8135869
   PubMed Web of Science ®Google Scholar
• Sundseth SS, Waxman DJ. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J Biol Chem 1992; 267:3915 - 21; PMID: 1740439
   PubMed Web of Science ®Google Scholar
• Yamada J, Sugiyama H, Tamura H, Suga T. Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. Arch Biochem Biophys 1994; 315:555 - 7; http://dx.doi.org/10.1006/abbi.1994.1536; PMID: 7986103
   PubMed Web of Science ®Google Scholar
• Zhou YC, Waxman DJ. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b. J Biol Chem 1999; 274:2672 - 81; http://dx.doi.org/10.1074/jbc.274.5.2672; PMID: 9915797
   PubMed Web of Science ®Google Scholar
• Panzer U, Zahner G, Wienberg U, Steinmetz OM, Peters A, Turner JE, et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrol Dial Transplant 2008; 23:3776 - 85; http://dx.doi.org/10.1093/ndt/gfn361; PMID: 18596134
   PubMed Web of Science ®Google Scholar